Advenchen Laboratories Nanjing Ltd.

This early-stage study tests a new drug called AL58805 in about 40 people with advanced solid tumors who have no other treatment options. The main goal is to find a safe dose and understand side effects. Researchers will also measure how the drug moves through the body.